IL-6 inhibitor monoclonal antibody

This page covers all IL-6 inhibitor monoclonal antibody drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting IL-6 or IL-6 receptor, Interleukin-6 (IL-6), IL-6.

Targets

IL-6 or IL-6 receptor · Interleukin-6 (IL-6) · IL-6

Marketed (1)

• TCI507 · National Taiwan University Hospital · Immunology
  TCI507 is a monoclonal antibody that targets and inhibits IL-6 signaling to reduce inflammatory responses.

Phase 3 pipeline (3)

• Ziltivekimab C · Novo Nordisk A/S · Cardiovascular
  Ziltivekimab is a monoclonal antibody that inhibits interleukin-6 (IL-6) signaling to reduce inflammation and cardiovascular risk.
• Placebo (ziltivekimab) · Novo Nordisk A/S · Cardiovascular
  Ziltivekimab is a monoclonal antibody that inhibits interleukin-6 (IL-6) signaling to reduce inflammation.
• AV024 · MedImmune LLC · Immunology
  AV024 is a monoclonal antibody that targets and inhibits IL-6 signaling to reduce inflammatory responses.